TransCode Therapeutics, Inc. (RNAZ) has a market capitalization of $8.16M and trades at $8.90. The 52-week range is 6.083-22.036.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-47.14.
The stock has a beta of 1.50, operates in the Healthcare sector.
